We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

PET Infusion System Has Workflow Enhancements Upgrade

By MedImaging International staff writers
Posted on 09 Jun 2011
A next-generation positron emission tomography (PET) infusion system features a new design that is 38% smaller, power-driven, and includes enhancements to technologists' workflow.

Medrad, Inc. (Warrendale, PA, USA), a business of Bayer HealthCare (Leverkusen, Germany), has announced the launch of the next generation Intego infusion system. The new Intego will be on display at the annual meeting of the Society of Nuclear Medicine (SNM), June 4-8, 2011, in San Antonio (TX, USA).

The Intego PET infusion system, originally launched in 2008, remains the only US Food and Drug Administration (FDA)-cleared device for automated, controlled infusion of F18-fluorodeoxyglucose (FDG) and F18-NaF, the most common PET diagnostic imaging agents used in oncology. Intego PET infusion systems have been sold worldwide.

"The new Intego demonstrates our commitment to continued innovation and leadership in molecular imaging. Now, in an even smaller, more mobile design, Intego can significantly reduce radiation exposure and improve patient care. This is just another way we are driving smarter, safer, simpler PET," said Doug Descalzi, executive director, Medrad Molecular Imaging.

Related Links:
Medrad



Ultrasonic Pocket Doppler
SD1
Computed Tomography System
Aquilion ONE / INSIGHT Edition
New
Mammography System (Analog)
MAM VENUS
X-ray Diagnostic System
FDX Visionary-A

Latest Nuclear Medicine News

Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections
09 Jun 2011  |   Nuclear Medicine

New Imaging Approach Could Reduce Need for Biopsies to Monitor Prostate Cancer
09 Jun 2011  |   Nuclear Medicine

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
09 Jun 2011  |   Nuclear Medicine